Methyl thieno[3,2-c]pyridine-4-carboxylate, 97%, 100mg

(2S)-1-(azepan-1-yl)propan-2-amine dihydrochloride, 95.0%, 250mg

Recipiente di reazione a flangia piatta, cilindrico, graduato, con camicia di rinvenimento e sottovuoto e valvola di drenaggio, DN 100, 4000 ml, 250 mm, 1 Pezzo

Thymidine 5'-diphosphoric acid trisodium salt, 90%, 250mg

(2,4-Dichloro-benzoylamino)-acetic acid, 90.0%, 2.5g

(R)-2-((tert-Butoxycarbonyl)amino)-3-(thiazol-4-yl)propanoic acid, 95.0%, 250mg

Spiro[4.4]nonane-4,9-dione, 98+%, 100mg

2-(Benzyloxy)-N-methylaniline hydrochloride, 97%, 5g

2-({[(tert-Butoxy)carbonyl]amino}methyl)pyridine-4-carboxylic acid, 98%, 5g

tert-Butyl 4-(5-chloro-6-oxo-1,6-dihydropyridazin-4-yl)piperazine-1-carboxylate, 1g

Octadecyldimethyl (dimethylamino) silane, 10g

Ethyl N-(mesitylsulfonyl)oxyacetimidate, 95.0%, 500g

(2-(thiophen-3-yl)phenyl)methanamine, 95.0%, 500mg